Join
Live feed
·
PRReleasevia Quantisnow
AtaiBeckley Inc. logo

AtaiBeckley's BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs

ByQuantisnow·Wall Street's wire, on your screen.
ATAI· AtaiBeckley Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATAI (AtaiBeckley Inc.) and more on Quantisnow.